Evolution in the understanding of the pathophysiological basis of portal hypertension: How changes in paradigm are leading to successful new treatments

Jaume Bosch, Roberto J. Groszmann, Vijay Shah

Research output: Contribution to journalArticle

68 Citations (Scopus)

Abstract

Among the common complication of cirrhosis portal hypertension witnessed a major improvement of prognosis during the past decades. Principally due to the introduction of rational treatments based on new pathophysiological paradigms (concepts of thought) developed in the 1980s. The best example being the use of non-selective beta-blockers and of vasopressin analogs, somatostatin, and its analogs. Further refinement in the knowledge of the molecular mechanisms involved in the regulation of both the splanchnic and hepatic circulation has led to the emergence of new treatments, which are based on evidence that show not only structural but also vasoactive components increase the hepatic vascular resistance, as well as of angiogenesis. This knowledge and future improvements will most likely result in more effective treatment of portal hypertension and effective prevention of its complications in early stages.

Original languageEnglish (US)
Pages (from-to)S121-S130
JournalJournal of Hepatology
Volume62
Issue numberS1
DOIs
StatePublished - 2015

Fingerprint

Portal Hypertension
Splanchnic Circulation
Liver Circulation
Somatostatin
Vasopressins
Vascular Resistance
Fibrosis
Liver

Keywords

  • Endothelial dysfunction
  • Hepatic stellate cells
  • Hyperdynamic syndrome
  • Liver sinusoidal endothelial cells
  • Portal pressure
  • Splanchnic vasodilation

ASJC Scopus subject areas

  • Hepatology

Cite this

Evolution in the understanding of the pathophysiological basis of portal hypertension : How changes in paradigm are leading to successful new treatments. / Bosch, Jaume; Groszmann, Roberto J.; Shah, Vijay.

In: Journal of Hepatology, Vol. 62, No. S1, 2015, p. S121-S130.

Research output: Contribution to journalArticle

@article{bbaf341e32b94915843eae7215c0a07b,
title = "Evolution in the understanding of the pathophysiological basis of portal hypertension: How changes in paradigm are leading to successful new treatments",
abstract = "Among the common complication of cirrhosis portal hypertension witnessed a major improvement of prognosis during the past decades. Principally due to the introduction of rational treatments based on new pathophysiological paradigms (concepts of thought) developed in the 1980s. The best example being the use of non-selective beta-blockers and of vasopressin analogs, somatostatin, and its analogs. Further refinement in the knowledge of the molecular mechanisms involved in the regulation of both the splanchnic and hepatic circulation has led to the emergence of new treatments, which are based on evidence that show not only structural but also vasoactive components increase the hepatic vascular resistance, as well as of angiogenesis. This knowledge and future improvements will most likely result in more effective treatment of portal hypertension and effective prevention of its complications in early stages.",
keywords = "Endothelial dysfunction, Hepatic stellate cells, Hyperdynamic syndrome, Liver sinusoidal endothelial cells, Portal pressure, Splanchnic vasodilation",
author = "Jaume Bosch and Groszmann, {Roberto J.} and Vijay Shah",
year = "2015",
doi = "10.1016/j.jhep.2015.01.003",
language = "English (US)",
volume = "62",
pages = "S121--S130",
journal = "Journal of Hepatology",
issn = "0168-8278",
publisher = "Elsevier",
number = "S1",

}

TY - JOUR

T1 - Evolution in the understanding of the pathophysiological basis of portal hypertension

T2 - How changes in paradigm are leading to successful new treatments

AU - Bosch, Jaume

AU - Groszmann, Roberto J.

AU - Shah, Vijay

PY - 2015

Y1 - 2015

N2 - Among the common complication of cirrhosis portal hypertension witnessed a major improvement of prognosis during the past decades. Principally due to the introduction of rational treatments based on new pathophysiological paradigms (concepts of thought) developed in the 1980s. The best example being the use of non-selective beta-blockers and of vasopressin analogs, somatostatin, and its analogs. Further refinement in the knowledge of the molecular mechanisms involved in the regulation of both the splanchnic and hepatic circulation has led to the emergence of new treatments, which are based on evidence that show not only structural but also vasoactive components increase the hepatic vascular resistance, as well as of angiogenesis. This knowledge and future improvements will most likely result in more effective treatment of portal hypertension and effective prevention of its complications in early stages.

AB - Among the common complication of cirrhosis portal hypertension witnessed a major improvement of prognosis during the past decades. Principally due to the introduction of rational treatments based on new pathophysiological paradigms (concepts of thought) developed in the 1980s. The best example being the use of non-selective beta-blockers and of vasopressin analogs, somatostatin, and its analogs. Further refinement in the knowledge of the molecular mechanisms involved in the regulation of both the splanchnic and hepatic circulation has led to the emergence of new treatments, which are based on evidence that show not only structural but also vasoactive components increase the hepatic vascular resistance, as well as of angiogenesis. This knowledge and future improvements will most likely result in more effective treatment of portal hypertension and effective prevention of its complications in early stages.

KW - Endothelial dysfunction

KW - Hepatic stellate cells

KW - Hyperdynamic syndrome

KW - Liver sinusoidal endothelial cells

KW - Portal pressure

KW - Splanchnic vasodilation

UR - http://www.scopus.com/inward/record.url?scp=84943381123&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84943381123&partnerID=8YFLogxK

U2 - 10.1016/j.jhep.2015.01.003

DO - 10.1016/j.jhep.2015.01.003

M3 - Article

C2 - 25920081

AN - SCOPUS:84943381123

VL - 62

SP - S121-S130

JO - Journal of Hepatology

JF - Journal of Hepatology

SN - 0168-8278

IS - S1

ER -